Thomas Duthy
Vermögen: 177 032 $ am 31.10.2026
Vermögen: 177 032 $ am 31.10.2026
Thomas Duthy is the founder of Nemean Group Pty Ltd., established in 2018, serving as Chief Executive Officer & Director.
Current jobs include Non-Executive Chairman at OncoSil Medical Ltd. starting in 2025, Non-Executive Director at Liver Foundation of Western Australia, Investor Relations Contact at Limeade, Inc., Member at Australian Institute of Co. Directors, Member at Australasian Investor Relations Association Ltd, and Investor Relation Contact at Mayne Pharma Group Ltd. Former jobs include Non-Executive Chairman at Arovella Therapeutics Ltd. from 2023 to 2025, Independent Non-Executive Director at Vitasora Health Ltd. in 2018, Non-Executive Director at Vitasora Health Ltd. from 2020 to 2022, Executive Director at Neurotech International Ltd. from 2022 to 2025, Non-Executive Director at Neurizon Therapeutics Ltd. in 2024, Executive Director at Invex Therapeutics Ltd. from 2020 to 2025, Head-Investor Relations at Nova Eye Medical Ltd., Analyst at Taylor Collison Ltd., and Global Head-Investor Relations at Sirtex Medical Pty Ltd. from 2014 to 2018.
Education includes a doctorate from the University of Adelaide and an MBA from Deakin University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.07.2025 | 4’747’444 ( 0.39% ) | 177 032 $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOSIL MEDICAL LIMITED | Vorsitzender | 01.10.2025 |
| LIMEADE | Investor Relations Kontakt | - |
| MAYNE PHARMA GROUP LIMITED | Investor Relations Kontakt | - |
Nemean Group Pty Ltd. | Vorstandsvorsitzender | 01.10.2018 |
Liver Foundation of Western Australia | Direktor/Vorstandsmitglied | - |
Australasian Investor Relations Association
Australasian Investor Relations Association Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for investor relations professionals | Corporate Officer/Principal | - |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| INVEX THERAPEUTICS LTD | Direktor/Vorstandsmitglied | 07.11.2025 |
| AROVELLA THERAPEUTICS LIMITED | Vorsitzender | 01.06.2025 |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 17 |
|---|---|
Limeade, Inc.
Limeade, Inc. Packaged SoftwareTechnology Services Develops employee well-being and HR related software platform | Technology Services |
Nova Eye Medical Ltd.
Nova Eye Medical Ltd. Medical SpecialtiesHealth Technology Manufactures ophthalmic laser and ultrasound systems | Health Technology |
Sirtex Medical Pty Ltd.
Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of treatment for liver cancer | Commercial Services |
University of Adelaide
University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arovella Therapeutics Ltd.
Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
Neurizon Therapeutics Ltd.
Neurizon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceutical products | Health Technology |
OncoSil Medical Ltd.
OncoSil Medical Ltd. Medical SpecialtiesHealth Technology Develops and commercializes neurology services including those for pancreatic cancer | Health Technology |
Deakin University
Deakin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Respiri Ltd.
Respiri Ltd. Medical SpecialtiesHealth Technology Engages in research, development and commercialization of medical devices | Health Technology |
Taylor Collison Ltd.
Taylor Collison Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which develops and manufactures proprietary and generic products | Health Technology |
Australasian Investor Relations Association
Australasian Investor Relations Association Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for investor relations professionals | Commercial Services |
Neurotech International Ltd.
Neurotech International Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and markets neurotechnology devices | Health Technology |
Invex Therapeutics Ltd.
Invex Therapeutics Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company and develops therapeutics for neurological conditions | Health Technology |
Liver Foundation of Western Australia | |
Nemean Group Pty Ltd. |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen